AKRO INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Akero Therapeutics, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Case
GlobeNewswire
SAN DIEGO, May 04, 2024 (GLOBE NEWSWIRE) -- *Robbins Geller Rudman & Dowd LLP* announces that it has filed a class action lawsuit..